AnGes

JP EN

COVID-19

In September 2022, AnGes decides discontinuation of development of DNA vaccine for original Wuhan strain of COVID-19
and start of research into improved DNA vaccine for COVID-19 Variants and Formulation for its intranasal delivery.

Information on COVID-19

It was decided that we should utilize the plasmid DNA technology developed by our company as quickly as possible to respond the urgent global challenge of preventing the spread of COVID-19 and formulate effective solutions; accordingly, we announced "Joint Development of a DNA Vaccine to Combat the Covid-19" on March 5, 2020.
Relevant information, including the matters we have worked on since the announcement, and answers to the questions we have received are set out below.

[DNA vaccine for COVID-19]

The DNA vaccine against COVID-19 is a plasmid DNA vaccine encoding the SARS-CoV-2 spike protein that opens the door to infection. It is expected to prevent COVID-19 or the condition of COVID-19 patients from deteriorating. Since the vaccine is engineered to express only the spikes on the viral surface, thereby producing antibodies, it is nonpathogenic and safe.

What are viruses?
What are viruses?
What are DNA vaccines?
What are DNA vaccines?
How the vaccine works:
The vaccine produces antibodies by expressing only the spikes within the body.
How the vaccine works How the vaccine works

COVID-19 News

2022年09月16日IR
About the September 7, 2022 Announcements
2021年11月05日Development
Novel Coronavirus (COVID-19) DNA Vaccine: Results of Phase 1/2 and Phase 2/3 Clinical Trials
2020年12月18日Development
Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment
2020年11月13日Development
FDA Allowance of IND Application For AV-001 for the Treatment of Hospitalized Patients with COVID-19
2020年09月08日Development
COVID-19 DNA vaccine development_Announcement of Collaboration Agreement with Brickell Biotech
2020年04月14日Development
COVID-19 DNA vaccine project : Peptite Institute joins for the peptide synthesis research
2020年04月10日Development
COVID-19 DNA vaccine project : Listed on the COVID-19 candidate vaccines in WHO (World Health Organization)
2020年04月07日Development
COVID-19 DNA vaccine project: Participation of EPS Group to support the clinical trials
2020年03月24日Development
COVID-19 DNA vaccine project: Completion of Plasmid DNA vaccine for preclinical studies
2020年03月13日Development
COVID-19 DNA vaccine project:Participation of Daicel corporation with a new administration device technology
2020年03月05日Development
AnGes and Osaka University launch joint DNA vaccine development against Coronavirus Disease 2019 (COVID-19)

contact
Contact us

AltStyle によって変換されたページ (->オリジナル) /